Brittany Harvey

8.7k total citations · 5 hit papers
16 papers, 4.7k citations indexed

About

Brittany Harvey is a scholar working on Oncology, Genetics and Neurology. According to data from OpenAlex, Brittany Harvey has authored 16 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Genetics and 4 papers in Neurology. Recurrent topics in Brittany Harvey's work include HER2/EGFR in Cancer Research (5 papers), Myasthenia Gravis and Thymoma (3 papers) and Breast Cancer Treatment Studies (3 papers). Brittany Harvey is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Myasthenia Gravis and Thymoma (3 papers) and Breast Cancer Treatment Studies (3 papers). Brittany Harvey collaborates with scholars based in United States, Germany and United Kingdom. Brittany Harvey's co-authors include Patricia A. Spears, Mitch Dowsett, Antonio C. Wolff, M. Elizabeth Hammond, Lisa M. McShane, Kimberly H. Allison, Pamela B. Mangu, Patrick L. Fitzgibbons, Wedad Hanna and Michael Bilous and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Muscle & Nerve.

In The Last Decade

Brittany Harvey

15 papers receiving 4.6k citations

Hit Papers

Human Epidermal Growth Fa... 2018 2026 2020 2023 2018 2018 2018 2021 2025 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
    2018 1.5k citations Antonio C. Wolff, M. Elizabeth Hammond et al. Journal of Clinical Oncology profile →
  2. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
    2018 1.0k citations Antonio C. Wolff, M. Elizabeth Hammond et al. Archives of Pathology & Laboratory Medicine profile →
  3. Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update
    2018 996 citations Kutluk Oktay, Brittany Harvey et al. Journal of Clinical Oncology profile →
  4. Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
    2021 592 citations Larissa A. Korde, Mark R. Somerfield et al. Journal of Clinical Oncology profile →
  5. Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update
    2025 18 citations Ko Un Park, Mark R. Somerfield et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brittany Harvey United States 11 2.5k 1.7k 1.0k 989 829 16 4.7k
Hatem A. Azim Belgium 36 3.6k 1.4× 1.6k 1.0× 213 0.2× 1.1k 1.1× 703 0.8× 120 5.5k
M. Castiglione Switzerland 26 2.8k 1.1× 2.5k 1.5× 640 0.6× 311 0.3× 442 0.5× 48 5.0k
Chikako Shimizu Japan 30 2.1k 0.8× 689 0.4× 707 0.7× 395 0.4× 276 0.3× 180 3.7k
José Bines Brazil 22 2.7k 1.1× 1.4k 0.8× 512 0.5× 424 0.4× 238 0.3× 94 3.7k
Charles Coutant France 34 1.5k 0.6× 1.6k 1.0× 413 0.4× 198 0.2× 1.3k 1.6× 205 4.4k
Jacqueline S. Jeruss United States 32 1.3k 0.5× 1.1k 0.6× 186 0.2× 1.0k 1.0× 588 0.7× 106 3.6k
Bernd Gerber Germany 38 3.9k 1.5× 4.4k 2.6× 990 1.0× 342 0.3× 336 0.4× 140 7.3k
Heinz Koelbl Germany 42 1.2k 0.5× 620 0.4× 260 0.3× 562 0.6× 716 0.9× 211 5.3k
S. Eva Singletary United States 40 1.8k 0.7× 2.5k 1.5× 556 0.5× 419 0.4× 229 0.3× 84 4.8k
Cecile T.M. Brekelmans Netherlands 27 1.3k 0.5× 1.6k 0.9× 790 0.8× 263 0.3× 472 0.6× 58 4.2k

Countries citing papers authored by Brittany Harvey

Since Specialization
Citations

This map shows the geographic impact of Brittany Harvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brittany Harvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brittany Harvey more than expected).

Fields of papers citing papers by Brittany Harvey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brittany Harvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brittany Harvey. The network helps show where Brittany Harvey may publish in the future.

Co-authorship network of co-authors of Brittany Harvey

This figure shows the co-authorship network connecting the top 25 collaborators of Brittany Harvey. A scholar is included among the top collaborators of Brittany Harvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brittany Harvey. Brittany Harvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Park, Ko Un, Mark R. Somerfield, Muriel Brackstone, et al.. (2025). Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update. Journal of Clinical Oncology. 43(14). 1720–1741. 18 indexed citations breakdown →
2.
3.
Korde, Larissa A., Mark R. Somerfield, Lisa A. Carey, et al.. (2021). Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline. Journal of Clinical Oncology. 39(13). 1485–1505. 592 indexed citations breakdown →
4.
Vu, Tuan, Brittany Harvey, Niraja Suresh, Jerrica Farias, & Clifton L. Gooch. (2021). Eculizumab during Pregnancy in a Patient with Treatment-Refractory Myasthenia Gravis: A Case Report. Case Reports in Neurology. 13(1). 65–72. 17 indexed citations
5.
6.
Suresh, Niraja, Brittany Harvey, Chuanhai Cao, et al.. (2020). An Open-Label, Prospective Study Evaluating the Clinical and Immunological Effects of Higher Dose Granulocyte Colony–Stimulating Factor in ALS. Journal of Clinical Neuromuscular Disease. 21(3). 127–134. 4 indexed citations
7.
Tung, Nadine, Judy C. Boughey, Lori J. Pierce, et al.. (2020). Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline. Journal of Clinical Oncology. 38(18). 2080–2106. 182 indexed citations
8.
Oktay, Kutluk, Brittany Harvey, Ann H. Partridge, et al.. (2018). Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. Journal of Clinical Oncology. 36(19). 1994–2001. 996 indexed citations breakdown →
9.
Wolff, Antonio C., M. Elizabeth Hammond, Kimberly H. Allison, et al.. (2018). Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. Journal of Clinical Oncology. 36(20). 2105–2122. 1545 indexed citations breakdown →
10.
Wolff, Antonio C., M. Elizabeth Hammond, Kimberly H. Allison, et al.. (2018). HER2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update Summary. Journal of Oncology Practice. 14(7). 437–441. 109 indexed citations
11.
Oktay, Kutluk, Brittany Harvey, & Alison W. Loren. (2018). Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update Summary. Journal of Oncology Practice. 14(6). 381–385. 95 indexed citations
12.
Wolff, Antonio C., M. Elizabeth Hammond, Kimberly H. Allison, et al.. (2018). Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. Archives of Pathology & Laboratory Medicine. 142(11). 1364–1382. 1018 indexed citations breakdown →
13.
Wolff, Antonio C., M. Elizabeth Hammond, Kimberly H. Allison, et al.. (2018). Reply to C. Murray et al and V. Martin et al. Journal of Clinical Oncology. 36(35). 3524–3525.
14.
Neuss, Michael N., Terry Gilmore, Amy L. Billett, et al.. (2017). 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology. Oncology nursing forum. 44(1). 31–43. 62 indexed citations
15.
Neuss, Michael N., Terry Gilmore, Amy L. Billett, et al.. (2016). 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology. Journal of Oncology Practice. 12(12). 1262–1271. 75 indexed citations
16.
Ashton, Melanie M., Michael Berk, Chirk Jenn Ng, et al.. (2016). The efficacy of adjunctive Garcinia mangostana Linn pericarp for bipolar depression: a 24-week double-blind, randomised, placebo controlled trial. Deakin Research Online (Deakin University). 168–168. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hatem A. Azim Breakdown of academic impact, for papers by M. Castiglione Breakdown of academic impact, for papers by Chikako Shimizu Breakdown of academic impact, for papers by José Bines Breakdown of academic impact, for papers by Charles Coutant Breakdown of academic impact, for papers by Jacqueline S. Jeruss Breakdown of academic impact, for papers by Bernd Gerber Breakdown of academic impact, for papers by Heinz Koelbl Breakdown of academic impact, for papers by S. Eva Singletary Breakdown of academic impact, for papers by Cecile T.M. Brekelmans
Rankless by CCL
2026